Clinical Report: Curative Lobectomy Outcomes in Elderly NSCLC Patients Over a Decade

Overview

This retrospective study of 1221 NSCLC patients aged over 60 undergoing lobectomy found that surgery with curative intent is feasible in elderly and very elderly patients. While overall survival was significantly poorer in patients over 80 years compared to those aged 60–69, progression-free survival did not differ significantly by age.

Background

Non-small cell lung cancer (NSCLC) constitutes approximately 80% of lung cancer cases and predominantly affects older adults. Surgical resection, particularly lobectomy, remains a cornerstone of curative treatment in operable stages. However, the suitability and outcomes of surgery in elderly patients remain debated due to concerns about comorbidities and postoperative complications. This study evaluates the viability and oncological outcomes of lobectomy in elderly NSCLC patients treated at a certified lung cancer center over ten years.

Data Highlights

Key Findings

• Length of hospital stay increased significantly with advancing age (p < 0.001).
• Older patients had more comorbidities, with postoperative cardiac arrhythmias occurring significantly more often (p = 0.02).
• Kaplan–Meier and multivariate Cox regression analyses showed significantly poorer overall survival in patients aged over 80 compared to those aged 60–69.
• Progression-free survival was not significantly associated with patient age.
• Surgical treatment with curative intent is feasible and yields comparable oncological outcomes in elderly and very elderly NSCLC patients.
• Individual patient selection based on age and comorbidities is recommended.

Clinical Implications

Curative lobectomy should be considered a viable treatment option for elderly NSCLC patients, including those over 80, with careful preoperative assessment. Although older patients may experience longer hospital stays and higher rates of postoperative cardiac arrhythmias, progression-free survival remains unaffected by age. Tailored patient selection is essential to optimize outcomes and minimize risks.

Conclusion

Surgical resection with curative intent in elderly NSCLC patients is feasible and provides oncological outcomes comparable to younger cohorts, though overall survival declines in patients over 80. Individualized evaluation is crucial to balance benefits and risks in this population.

References

1. Yancik R 2005 -- Population aging and cancer: a cross-national concern
2. Gonzalez-Aragoneses F et al 2009 -- Lung cancer surgery in the elderly
3. Howington JA et al 2013 -- Treatment of stage I and II non-small cell lung cancer
4. Liu HC et al 2013 -- Surgery for elderly lung cancer
5. Shiono S et al 2013 -- Postoperative complications in elderly patients after lung cancer surgery
6. Laohathai S et al 2019 -- Clinical and functional outcomes after curative resection in octogenarians